In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CHA Biotech Co. Ltd.

Latest From CHA Biotech Co. Ltd.

Nature Cell’s Stem Cell Alzheimer’s Therapy Advances Amid Failures

Nature Cell is set to begin a groundbreaking clinical trial in the US of a novel autologous stem cell therapy for Alzheimer's disease, a new approach likely to gain attention amid other high profile failures in the challenging indication.

Research & Development Neurology

Deals Shaping the Medical Industry, September 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2016.

Deals BioPharmaceutical

CHA, Sorrento JV Highlights Korean Immuno-Oncology Appetite

Sorrento and CHA Biotech’s agreement to form a CAR-NK cell therapy joint venture is very much “on trend”, being the latest in a recent series of immuno-oncology collaborations between Korean and foreign firms and indicating a rapidly growing appetite for assets in the field.

Research & Development Deals

Biostar, Kangstem Expand Stem Cell Therapy Pipelines Into AD, Psoriasis

Biostar Group and Kangstem Biotech are expanding their stem cell therapy pipelines via additional indications and a joint development deal, marking a further expansion of South Korea’s activities in the field into the new areas of Alzheimer’s and psoriasis.

BioPharmaceutical Asia Pacific
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • CHA Biotech Co. Ltd.
  • Senior Management
  • Jong-soo Choi, CEO
  • Contact Info
  • CHA Biotech Co. Ltd.
    Phone: (82) 31 881 7400
    Vision Bldg., 1st Fl.
    Seoul, 606-16
    South Korea